EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieQualitative StudieOpen Access · CC BY 4.0

Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative study

Abdul Salam, Tracey Laba, Rupasvi Dhurjati, Lakshmi K Josyula, Asita de Silva, Pavithra Godamunne, Rama Guggilla, Stephen Jan, Pallab Kumar Maulik, Nitish Naik, Anushka Patel, Arunasalam Pathmeswaran und 4 weitere

BMJ Open · 2025

DOI: 10.1136/bmjopen-2025-101689 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift BMJ Open, 2025. Verfasst von Abdul Salam und 15 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health India, New Delhi, India asalam@georgeinstitute.org.in. Hauptthemen laut MEDLINE: Hypertension, Antihypertensive Agents. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC) Australia, The Global Alliance for Chronic Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High blood pressure (BP) is a significant global health issue, with many treated patients failing to achieve BP control. The Triple Pill vs Usual Care Management for Patients with Mild-to-Moderate Hypertension (TRIUMPH) trial evaluated the effectiveness, cost-effectiveness and acceptability of early use of low-dose triple fixed-dose combination of BP-lowering drugs (‘triple pill’) compared with usual care in the management of hypertension. The TRIUMPH trial showed superior BP control with the triple pill strategy compared with usual care. This process evaluation of the TRIUMPH trial aimed to explore the contextual factors that influenced the trial outcomes, implementation of the triple pill strategy, mechanisms of its effects and potential barriers and facilitators for implementing the triple pill strategy in routine practice.

Methods

Guided by the UK Medical Research Council’s framework, semistructured interviews were conducted with 23 patients and 13 healthcare providers involved in the TRIUMPH trial. Data were analysed using the framework analysis method in NVivo.

Results

Hypertension care in Sri Lanka was hindered by the absence of systematic screening and overcrowded public clinics. Despite free medication provision at public clinics, long waiting times and occasional stock-outs posed challenges. In the TRIUMPH trial, both intervention and usual care were delivered in the context of ‘better than usual’ care, including team-based management, reduced waiting times, monetary assistance for travel, routine adherence monitoring and intensive follow-up. The triple pill strategy provided a simplified regimen, better access to BP-lowering medications and better BP-lowering efficacy. Key barriers to implementation in routine practice included the triple pill’s large size, therapeutic inertia and restrictive regulatory policies regarding fixed-dose combinations.

Conclusions

Implementation of the triple pill strategy into routine practice requires health system strengthening, provider training and supportive policy measures to replicate its effectiveness seen in the trial. Trial registration number ACTRN12612001120864, SLCTR/2015/020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionAntihypertensive AgentsHumansFemaleMaleQualitative ResearchMiddle AgedDrug CombinationsSri LankaAgedCost-Benefit AnalysisDrug Therapy, CombinationAdult

Stichwörter der Autor:innen

Blood PressureCARDIOLOGYHypertensionMeta-AnalysisSystematic Review

Substanzen

Antihypertensive AgentsDrug Combinations

Autor:innen und Institutionen

  • The George Institute for Global Health India, New Delhi, India asalam@georgeinstitute.org.in.
  • University of New South Wales, Sydney, New South Wales, Australia.
  • Manipal Academy of Higher Education, Manipal, India.
  • The University of Sydney, Sydney, New South Wales, Australia.
  • The George Institute for Global Health India, Telangana, Hyderabad, India.
  • Indian Institute of Public Health, Hyderabad, Telangana, India.

Förderung

  • National Health and Medical Research Council (NHMRC) Australia
  • The Global Alliance for Chronic Diseases

Zitieren

APA

Salam, A., Laba, T., Dhurjati, R., Josyula, L. K., de Silva, A., Godamunne, P., Guggilla, R., Jan, S., Maulik, P. K., Naik, N., Patel, A., Pathmeswaran, A., Prabhakaran, D., Rodgers, A., Selak, V., & Webster Griffiths, R. (2025). Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative study. BMJ Open. https://doi.org/10.1136/bmjopen-2025-101689

Vancouver

Salam A, Laba T, Dhurjati R, Josyula LK, de Silva A, Godamunne P, et al. Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative study. BMJ Open. 2025. doi:10.1136/bmjopen-2025-101689

BibTeX
@article{Salam2025,
  author = {Salam, Abdul and Laba, Tracey and Dhurjati, Rupasvi and Josyula, Lakshmi K and de Silva, Asita and Godamunne, Pavithra and Guggilla, Rama and Jan, Stephen and Maulik, Pallab Kumar and Naik, Nitish and Patel, Anushka and Pathmeswaran, Arunasalam and Prabhakaran, Dorairaj and Rodgers, Anthony and Selak, Vanessa and Webster Griffiths, Ruth},
  title = {Process evaluation of a randomised trial of a triple low-dose combination pill strategy to improve hypertension control: a qualitative study},
  journal = {BMJ Open},
  year = {2025},
  doi = {10.1136/bmjopen-2025-101689}
}
Kostenlos starten →